Peter D. Weinberg, MBA; Jennie Hounshell, BA; Laurence A. Sherman, MD, JD; John Godwin, MD; Shirin Ali, BA; Cecilia Tomori, BA; Charles L. Bennett, MD, PhD
Requests for Single Reprints: Charles Bennett, MD, PhD, Veterans Affairs Medical Sciences Building, 400 East Ontario Street, Suite 205, Chicago, IL 60611; e-mail, firstname.lastname@example.org.
Current Author Addresses: Mr. Weinberg and Dr. Bennett: Division of Hematology-Oncology of the Department of Medicine, Northwestern University, 400 East Ontario Street, Chicago, IL 60611.
Ms. Hounshell: University of Pittsburgh School of Medicine, Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261.
Dr. Sherman: Department of Pathology, Northwestern University Medical School, 303 East Chicago Avenue, Chicago, IL 60611.
Dr. Godwin: Cardinal Bernardin Cancer Center, 2160 South First Avenue, Maywood, IL 60513.
Ms. Ali: University of Virginia School of Medicine, Box 800739, Charlottesville, VA 22908-0739.
Ms. Tomori: Department of Sociology, University of Michigan, 500 South State Street, Room 3012, Ann Arbor, MI 48109-1382.
Ensuring the safety of the blood supply connects politics and science. The business and service sectors share responsibility for the collection and processing of blood donations, and government agencies perform regulatory and surveillance roles. The onset of the AIDS epidemic has challenged the interface among these systems, leading to widespread fears about compromised safety of the blood supply. Because of public concern about blood-supply decisions made in the 1980s, developed countries in the 1990s established reimbursement programs for persons with transfusion-acquired viral infections from blood or blood products, adopted diagnostic tests and procedures that improved the safety of the blood supply, and held criminal judicial investigations of government officials and industry leaders accused of delaying implementation of potential blood-safety measures. In contrast, developing countries continue to struggle with blood-supply safety issues. This paper summarizes the current status of these safety concerns in developed countries, where viral transmission from contaminated blood or blood products is extremely rare, and in developing countries, where up to 10% of HIV infections result from transfusion of blood or blood products.
Weinberg PD, Hounshell J, Sherman LA, Godwin J, Ali S, Tomori C, et al. Legal, Financial, and Public Health Consequences of HIV Contamination of Blood and Blood Products in the 1980s and 1990s. Ann Intern Med. ;136:312–319. doi: 10.7326/0003-4819-136-4-200202190-00011
Download citation file:
Published: Ann Intern Med. 2002;136(4):312-319.
HIV, Infectious Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use